StockData
LFTD Partners Inc. logo

LFTD Partners Inc. (LIFD) stock

LIFDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

LFTD Partners free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

LFTD Partners's free cash flow for the twelve months ending Mar 31, 2026 was $1.26M. For fiscal 2025 it was $1.20M. The highest annual figure on record is $5.25M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.20M–
FY2024Dec 31, 2024-$1.27M–
FY2023Dec 31, 2023-$150.74K-107.1%
FY2022Dec 31, 2022$2.12M-59.6%
FY2021Dec 31, 2021$5.25M–
FY2020Dec 31, 2020-$408.17K–
FY2019Dec 31, 2019-$611.50K–
FY2011Dec 31, 2011-$1.35M–
FY2010Dec 31, 2010-$138.26K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026$339.18K+23.5%
Q4 FY2025Dec 31, 2025$501.76K–
Q3 FY2025Sep 30, 2025$696.51K–
Q2 FY2025Jun 30, 2025-$273.01K–
Q1 FY2025Mar 31, 2025$274.60K-74.0%
Q4 FY2024Dec 31, 2024-$895.91K–
Q3 FY2024Sep 30, 2024-$334.28K–
Q4 FY2023Dec 31, 2023-$146.08K–
Q3 FY2023Sep 30, 2023$1.06M-56.7%
Q2 FY2023Jun 30, 2023-$1.02M-1079.8%
Q1 FY2023Mar 31, 2023-$39.58K-111.6%
Q4 FY2022Dec 31, 2022-$758.91K-163.6%
Q3 FY2022Sep 30, 2022$2.44M+25.0%
Q2 FY2022Jun 30, 2022$104.14K-93.0%
Q1 FY2022Mar 31, 2022$340.05K-44.9%
Q4 FY2021Dec 31, 2021$1.19M+58.9%
Q3 FY2021Sep 30, 2021$1.95M–
Q2 FY2021Jun 30, 2021$1.50M–
Q1 FY2021Mar 31, 2021$617.59K–
Q4 FY2020Dec 31, 2020$750.50K–
Q3 FY2020Sep 30, 2020-$386.53K–
Q2 FY2020Jun 30, 2020-$398.81K–
Q1 FY2020Mar 31, 2020-$373.34K–
Q4 FY2019Dec 31, 2019-$123.63K–
Q3 FY2019Sep 30, 2019-$141.39K–
Q2 FY2019Jun 30, 2019-$184.69K–
Q1 FY2019Mar 31, 2019-$161.79K–

More LFTD Partners figures

See a number that looks wrong?